The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Topiramate
Topiramate · TOPIRAMATE 50 mg/1 · Capsule · Oral · Advagen Pharma Ltd
NDC 72888-0230-05 · 500 CAPSULE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for topiramate (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA216683
- TE code
- AB
- Approval date
- May 27, 2025
- Patents / exclusivity
- 0 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | CGT | Feb 1, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Topiramate (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Advagen Pharma Ltd | TOPIRAMATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advagen Pharma Ltd | TOPIRAMATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | TOPIRAMATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | TOPIRAMATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | TOPIRAMATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Upsher-Smith Laboratories, LLC | TOPIRAMATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Upsher-Smith Laboratories, LLC | TOPIRAMATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Topiramate — NDC 72888-0230-05," retrieved September 3, 2026, https://drugdashboards.com/drug/72888023005.
Free to cite with attribution — see how the data is put together.